Form 8-K - Current report:
SEC Accession No. 0001193125-25-093531
Filing Date
2025-04-24
Accepted
2025-04-24 16:15:30
Documents
13
Period of Report
2025-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d806910d8k.htm   iXBRL 8-K 21675
  Complete submission text file 0001193125-25-093531.txt   143071

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btmd-20250422.xsd EX-101.SCH 2833
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20250422_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20250422_pre.xml EX-101.PRE 11247
15 EXTRACTED XBRL INSTANCE DOCUMENT d806910d8k_htm.xml XML 3639
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 25867523
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)